Georgopoulos, Vasileios
Smith, Stephanie
McWilliams, Daniel F.
Ferguson, Eamonn
Wakefield, Richard
Platts, Dorothy
Ledbury, Susanne
Wilson, Deborah
Walsh, David A.
Funding for this research was provided by:
Versus Arthritis (22462)
Pfizer UK (51708879)
Article History
Received: 18 June 2024
Accepted: 24 September 2024
First Online: 8 October 2024
Declarations
:
: Ethical approval were obtained from the North of Scotland Research Ethics Committee of the Health Research Authority, United Kingdom (REC: 20/NS/0036) and the University of Nottingham (Sponsor).
: Not applicable.
: Daniel McWilliams has grant support from Eli Lilly and Company and Union Chimique Belge; and active research collaborations with Orion Pharma and GSK. David Walsh has grant support from Eli Lilly and Company, Pfizer Inc., Union Chimique Belge, Orion Pharma, and GlaxoSmithKline plc. Other authors have no conflict of interests to declare.